own lab with experts in rheumatic diseases or immune diseases in particular we're looking at how in scleroderma for instance we can use strategies similar to tools to avoid giving strong immunosuppressants to patients who don't need them other colleagues this is William Pelham Susan Murphy and their team they're studying kids with ADHD and looking at how using similar data-driven strategies they can identify when kids can be benefit from behavioral therapy and we can avoid the need for giving them psychostimulants